Wen-Zhao Zhong (Jia-Tao Zhang, Jia Tao Zhang)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Locally Advanced

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Thoracic cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Molecular oncology

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Rui Fu, Jun Huang, Xiaoru Tian, Chaoyang Liang, Yuanyuan Xiong, Wen-Zhao Zhong, Benyuan Jiang, Song Dong, Yuhua Gong, Wei Gao, Fang Li, Yonglei Shi, Zhentian Liu, Xuan Gao, Rongrong Chen, Wen-Zhao Zhong, Yi Zhang
Postoperative circulating tumor DNA can refine risk stratification in resectable lung cancer: results from a multicenter study. Molecular oncology (2023)
Rui Fu, Jun Huang, Xiaoru Tian, Chaoyang Liang, Yuanyuan Xiong, Wen-Zhao Zhong, Benyuan Jiang, Song Dong, Yuhua Gong, Wei Gao, Fang Li, Yonglei Shi, Zhentian Liu, Xuan Gao, Rongrong Chen, Wen-Zhao Zhong, Yi Zhang
Postoperative circulating tumor DNA can refine risk stratification in resectable lung cancer: results from a multicenter study. Molecular oncology (2023)
Cunte Chen, Si-Yang Maggie Liu, Yuchen Han, Ming Han, Qiuxiang Ou, Hua Bao, Ling Xu, Yi-Kai Zhang, Wen-Zhao Zhong, Wen-Zhao Zhong, Qing Zhou, Xue-Ning Yang, Yang W Shao, Yi-Long Wu, Si-Yang Liu, Yangqiu Li
Poor prognosis of intra-tumoural TRBV6-6 variants in EGFR-mutant NSCLC: Results from the ADJUVANT-CTONG1104 trial. Clinical and translational medicine 12 (4) (2022)
Wen-Zhao Zhong, Song Dong, Li Yan Ji, Jia Ying Zhou, Zhi Hong Chen, Jian Su, Qing Ge Zhu, Meng Min Wang, E E Ke, Hao Sun, Xue Tao Li, Jin Ji Yang, Qing Zhou, Xu Chao Zhang, Xuan Gao, Xue Ning Yang, Xuefeng Xia, Xin Yi, Wen-Zhao Zhong, Yi Long Wu
Intratumoral genetic and immune microenvironmental heterogeneity in T4N0M0 (diameter ≥ 7 cm) non-small cell lung cancers. Thoracic cancer 13 (9) (2022)
Wen-Zhao Zhong, Si-Yang Liu, Wei Gao, Si-Yang Maggie Liu, Hong-Hong Yan, Liyan Ji, Yu Chen, Yuhua Gong, Hong-Lian Lu, Jun-Tao Lin, Kai Yin, Ben-Yuan Jiang, Qiang Nie, Ri-Qiang Liao, Song Dong, Yanfang Guan, Pingping Dai, Xu Chao Zhang, Jin-Ji Yang, Hai-Yan Tu, Xuefeng Xia, Xin Yi, Qing Zhou, Wen-Zhao Zhong, Xue-Ning Yang, Yi-Long Wu
Longitudinal Undetectable Molecular Residual Disease Defines Potentially Cured Population in Localized Non-Small Cell Lung Cancer. Cancer discovery 12 (7) (2022)
Zi-Hao Chen, Zhi-Yong Chen, Jing Kang, Xiang-Peng Chu, Rui Fu, Wen-Zhao Zhong, Yi-Fan Qi, Jing-Hua Chen, Jun-Tao Lin, Ben-Yuan Jiang, Xue-Ning Yang, Yi-Long Wu, Wen-Zhao Zhong, Qiang Nie
Investigation on the incidence and risk factors of lung cancer among Chinese hospital employees. Thoracic cancer 13 (15) (2022)
Cunte Chen, Si-Yang Maggie Liu, Yuchen Han, Qiuxiang Ou, Hua Bao, Ling Xu, Yi-Kai Zhang, Wen-Zhao Zhong, Wen-Zhao Zhong, Qing Zhou, Xue-Ning Yang, Yang W Shao, Yi-Long Wu, Si-Yang Liu, Yangqiu Li
Identification of TCR rearrangements specific for genetic alterations in EGFR-mutated non-small cell lung cancer: results from the ADJUVANT-CTONG1104 trial. Cancer immunology, immunotherapy : CII (2022)
Ben-Yuan Jiang, Wen-Zhao Zhong, Li-Xu Yan, Xiang-Peng Chu, Qiang Nie, Jian-Xiu Cui, Xue-Ning Yang, Wen-Zhao Zhong, Yi-Long Wu
Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors. Cancer communications (London, England) 41 (11) (2021)
Si-Yang Liu, Wen-Zhao Zhong, Yi-Long Wu
What We Have Learned From Adjuvant Therapy for Resected EGFR-Mutant Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Wen-Zhao Zhong, Qun Wang, Wei-Min Mao, Song-Tao Xu, Lin Wu, Yu-Cheng Wei, Yong-Yu Liu, Chun Chen, Ying Cheng, Rong Yin, Fan Yang, Sheng-Xiang Ren, Xiao-Fei Li, Jian Li, Cheng Huang, Zhi-Dong Liu, Shun Xu, Ke-Neng Chen, Shi-Dong Xu, Lun-Xu Liu, Ping Yu, Bu-Hai Wang, Hai-Tao Ma, Jin-Ji Yang, Hong-Hong Yan, Xue-Ning Yang, Si-Yang Liu, Qing Zhou, Yi-Long Wu
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2020)